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INTRODUCTION
In recent years, the incidence and mortality of colorectal cancer
(CRC) have increased, and it is now one of the most frequently
diagnosed cancers in Japan (1). CRC can be effectively prevented
by removing precancerous lesions diagnosed upon colonoscopy
(2-5). Indeed, the incidence and mortality of CRC have decreased
in United States as the screening rate of CRC using colonoscopy
has increased (6). The risk of CRC after a previous negative colono-
scopy is very low. Nevertheless, considerable numbers of CRCs
are diagnosed several years after colonoscopy (7-15) ; such lesions
are called “interval cancer” or “post-colonoscopy colorectal can-
cer” (16). A number of researches have suggested that a deficiency
in colonoscopy quality rather than accelerated tumor biology is the
cause of the majority of interval cancers occurring within 3-5 years
after a negative colonoscopy (6, 10, 16-20). Hence, interval cancer
represents a clinical problem urgently requiring a solution. Al-
though the distribution and predictors of interval cancers after
negative colonoscopy have been extensively studied, the morphol-
ogy of interval cancers in the early stage has not yet been studied
in detail.
Advanced adenoma is considered to represent the pre-stage of
life - threatening cancer and may be the most valid neoplastic sur-
rogate marker for present and future colorectal cancer risks (21).
Advanced colorectal neoplasia is a concept that merges invasive
cancer with advanced adenoma and is defined as cancer or adenoma
that is at least 10 mm in diameter and has high-grade dysplasia with
histological characteristics of villous or tubulovillous lesions, or a
combination thereof (22). As a general rule, the Paris classification
is usually used to depict the morphology of colorectal neoplasms
(23) ; however, different neoplastic growth types are sometimes
included in the same category of the Paris classification. For ex-
ample, even if lesions were classified as IIa in the Paris classifica-
tion, the biological behavior would differ between lesions with and
without a granular surface. Therefore, the pragmatic classification
of superficial neoplastic colorectal lesions is commonly used in
clinical practice (24). In the present study, using this classification,
we investigated the morphology and locations of post-colonoscopy
advanced neoplasms (PCANs), excludingT2 tumors, as a means
to characterize the early stage of PCANs, which are considered
likely to have been missed on the previous screening colonoscopy.
METHODS
Study design
This is a single-center, retrospective study of prospectively col-
lected data from April 2010 to September 2013. Data were obtained
from the endoscopic database in Kyoto Second Red Cross Hospital,
Kyoto, Japan. Consecutive colonoscopies performed during this
period were included in this study. Informed consent was obtained
from all individual participants in the study, and the study protocol
was approved by the institutional review board of Kyoto Second
Red Cross Hospital and conducted in accordance with the Decla-
ration of Helsinki (as revised in Tokyo, 2004). Patients were ex-
cluded from our analysis based on the following criteria : inflamma-
tory bowel diseases, familial adenomatous polyposis, colonoscopy
within 6 months, unknown history of previous colonoscopy, and un-
known family history. We analyzed the differences in morphologi-
cal characteristics and location of advanced neoplasms between
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PCANs and primary lesions, defined as lesions detected in their
first colonoscopy or in a subsequent colonoscopy performed more
than 5 years after the previous one. According to the pragmatic
classification, advanced neoplasms were divided into five groups
(Fig. 1), namely polypoid, flat, depressed, laterally spreading tumor
granular type (LST-G), and laterally spreading tumor non-granu-
lar type (LST-NG) lesions. Advanced cancers are difficult to classify
because of substantial changes in the original morphology ; there-
fore, advanced cancers classified as T2 or higher stages according
to the American Joint Committee on Cancer/TMN system (25) were
excluded from the final analysis.
Terminology
In the majority of studies reported, interval cancer or post-colono-
scopy colorectal cancer is defined as cancer lesions detected after
a previous colonoscopy within a 6- to 60-month period (16). In
reference to this definition, in the present study, we defined PCANs
as advanced neoplasms detected after a previous colonoscopy
within a 0.5- to 5.5 -year period. We also analyzed PCANs by sub-
dividing the lesions into two groups : lesions detected between 0.5
and 3.5 years (PCAN3 years), and between 3.5 and 5.5 years
(PCAN 4-5 years) after colonoscopy.
Laterally spreading tumors (LSTs) are neoplasms with a lateral
tumor growth of at least 10 mm in diameter, and are divided into
LST-G lesions, having a granular surface (0-IIa, 0 -Is+IIa, and 0-
IIa+Is), and LST-NG lesions, which lack a granular surface (0-IIa,
0 -IIa+IIc, and 0-IIc+IIa) (26). Flat lesions are defined as 0-IIa
lesions smaller than 10 mm in diameter. Depressed lesions are ex-
pressed as 0-IIc, 0 -IIa+IIc, and 0-Is+IIc lesions smaller than 10 mm
in diameter. Polypoid lesions are defined as 0-Is and 0-Ip lesions.
Advanced neoplasia includes advanced adenoma (defined as tu-
bular adenoma10 mm, adenoma with a villous histology, and/or
adenoma with high-grade dysplasia) or cancer withT1 (defined
as malignant cells beyond the muscularis mucosa). Adenoma with
high-grade dysplasia includes mucosal cancer. Traditional ser-
rated adenoma was included in the adenoma category. The right-
sided colon is defined as the oral side from the splenic flexure, and
the rest of the colon is defined as the left -sided colon.
Colonoscopy
The patients were instructed to take magnesium citrate the day
before colonoscopy as preparatory medication. On the morning
before the colonoscopy, polyethylene glycol was used to clean the
bowel ; when inadequate, an enema was given. All colonoscopies
were carried out or supervised by experienced endoscopists. As
a general rule, all polyps, except hyperplastic polyps5 mm, were
removed by cold polypectomy or endoscopic mucosal resection
during the procedure, while allT2 cancers and the majority of T1
cancers were resected by surgical intervention. Midazolam was
used only when a patient complained of severe pain.
Data collection and statistical analysis
We used an endoscopic database, recorded in Solemio ENDO
filing system Ver. 3.2 (Olympus Medical Systems Inc., Tokyo, Ja-
pan), for data collection. Each endoscopist input the following data
shortly after each colonoscopic procedure : age, sex, family his-
tory of CRC, past history of colonoscopy, indication of colonoscopy,
and the morphology and location of the detected lesions. The mor-
phology of the polyps was reviewed by experienced endoscopists
after the procedure. Each endoscopist input data regarding the
past history of colonoscopy by referring to the medical records
of the patients for the last 10 years, and also by asking the patients
whether they had previously undergone colonoscopy elsewhere.
We excluded patients who had previously undergone colonoscopy
at different hospitals, as we were unable to obtain exact information
on the results. After the histopathological findings were analyzed,
the endoscopists added the pathological data to the database.
Differences in the patient characteristics, including sex, family
history, or indication of colonoscopy, and in the characteristics of
the future advanced neoplasms including location, histology, and
morphology among each category were analyzed using the χ2 test.
Analysis of variance was also used for continuous variables such
as age. Statistical analyses were done using IBM SPSS statistics
version 22 (IBM SPSS, Armonk, NY, USA), with p0.05 consid-
ered statistically significant.
Fig. 1. Typical endoscopic images of 6 different types of advanced neoplasms. (A) Polypoid lesion (pedunculated type ; 0 - Ip), (B) polypoid lesion
(sessile type ; 0 - Is), (C) laterally spreading tumor granular type lesion (LST-G ; 0 - IIa+Is), (D) depressed lesion (0 - IIc), (E) flat lesion (0 - IIa), and
(F) laterally spreading tumor non-granular type lesion (LST-NG ; 0 - IIa). A, B, and C were classified as the polypoid group, and D, E, and F were
classified as the non-polypoid group in the present study.
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RESULTS
Patient characteristics
Data on consecutive colonoscopies (n=10,632) performed in
7,251 patients were collected, out of which 5,768 colonoscopies for
4,841 patients met all inclusion/exclusion criteria and were ana-
lyzed (Fig. 2). A total of 2,979 patients did not undergo colonoscopy
during the past 5.5 years or were tested for the first time (Table 1).
About one-third of these patients underwent colonoscopy because
of a positive fecal occult blood test (35.7% ; 1063/2979 cases). Half
of the patients who underwent repeated colonoscopy within the
0.5- to 5.5 -year period were subjected to surveillance colonoscopy
after polypectomy (50.2% ; 1399/2789 cases), which was similar
to the proportion of patients within the 0.5- to 3.5 -year period who
were subjected to surveillance colonoscopy (52.8% ; 1284/2431
cases) (Table 1). Older age and male sex were associated with
repeated colonoscopy within both the 0.5- to 5.5 -year and 0.5- to
3.5 -year periods (p0.001 for both), as was a family history of CRC
(p=0.002 and p=0.02, respectively).
Location and histological features of advanced neoplasms
Overall, 922 advancedneoplasms (including 217 cancers with
T2, 41 cancers with T1, and 173 mucosal cancers) were detected
during the study period, out of which 755 lesions were diagnosed
as primary lesions (Table 2). We detected 142 lesions of PCANs
during 0.5 to 3.5 years after colonoscopy (PCAN3 y), and the
number of PCANs increased to 167 lesions when collected from
0.5 to 5.5 years after colonoscopy (PCAN5 y). To test whether
PCANs with a relatively long interval after colonoscopy displayed
distinct characters, we analyzed PCANs detected 3.5-5.5 years
after the previous colonoscopy. However, there were no signifi-
cantly differences in the distribution of their location (p=0.560) and
histological features (p=0.207) between the PCAN 0.5-3.5 y and
PCAN 3.5-5.5 y groups (data not shown). Based on these findings,
we analyzed the characteristics of PCANs by comparing the differ-
ences between primary lesions and PCAN 3 y or PCAN 5 y.
First, we analyzed the location of PCANs. As shown in Table 2,
the incidence of advanced neoplasms in the right-sided colon
was significantly higher in the PCAN5 y (48.5%, p0.001) and
PCAN3 y (45.8%, p0.01) groups compared with that in the
primary group (34.0%). Especially, the incidence of advanced neo-
plasms in the transverse colon was doubled in the PCAN5 y
group when compared with that in the primary group (19.8% vs.
9.3%, p0.001), whereas the incidence was reversed in the rectum
between the PCAN5 y (9.0%) and primary groups (19.6%, p
0.01). Similar differences were observed when comparing the
PCAN3 y and primary groups (Table 2).
We detected a total of 258 cancers withT1 during the test pe-
riod (246 primary lesions in 234 patients and 12 PCAN5 y lesions
in 12 patients ; Table 2). Among the 258 cancers withT1, 210 out
of 246 (85.4%) in the primary group and 7 out of 12 (58.3%) in the
PCAN5 y group wereT2. As expected, the percentage of can-
cers withT1 in the PCAN5 y group (7.2%, 12/167 lesions) was
significantly lower compared with that in the primary group (p
0.001). Because of the small number of cancers withT1 in the
PCAN5 y group (12 lesions), we could not statistically com-
pare the histological characteristics of cancers withT1 between
PCANs and primary lesions. However, well -differentiated adeno-
carcinoma was the most dominant type for both the PCANs and
primary lesions (Table 2), whereas poorly differentiated and muci-
nous adenocarcinomas were detected only in the primary lesions.Fig. 2. Study flow.
Table 1. Characteristics of the study patients
Previous colonoscopy
Total
(% of total cases)
None or5.5 y
(% of 2,979 cases)
0.5 -3.5 y
(% of 2,431 cases)
0.5 -5.5 y
(% of 2,789 cases)
Cases 5,768 2,979 2,431 2,789
Male (%) 3,344 (58.0%) 1,555 (52.2%) 1,544 (63.5%)a 1,772 (63.5%)a
Age (years old, meanSD) 63.712.4 62.013.7 65.510.4a 65.510.5a
Family history of CRC 502 (8.7%) 226 (7.6%) 234 (9.6%)b 276 (9.9%)c
Indications
Fecal occult blood 1,298 (22.5%) 1,063 (35.7%) 157 (6.5%) 235 (8.4%)
Bloody stool 480 (8.3%) 390 (13.1%) 66 (2.7%) 90 (3.2%)
Abdominal symptoms 490 (8.5%) 366 (12.3%) 84 (3.5%) 124 (4.4%)
Surveillance after CRC operation 534 (9.3%) 13 (0.4%) 502 (20.6%) 521 (18.7%)
Surveillance after polypectomy 1,461 (25.3%) 62 (2.1%) 1,284(52.8%) 1,399 (50.2%)
Medical examination 886 (15.4%) 708 (23.8%) 129 (5.3%) 178 (6.4%)
Others 619 (10.7%) 377 (12.7%) 209 (8.6%) 242 (8.7%)
aSignificantly different compared with patients who did not undergo colonoscopy during the past 5.5 years or were tested for the first time (p0.001).
bSignificantly different compared with patients who did not undergo colonoscopy during the past 5.5 years or were tested for the first time (p=0.02).
cSignificantly different compared with patients who did not undergo colonoscopy during the past 5.5 years or were tested for the first time (p=0.002).
SD, standard deviation ; CRC, colorectal cancer
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As for the advanced adenomas, the incidences of adenomas with
high-grade dysplasia and villous adenomas were significantly
higher in the PCAN3 y and PCAN5 y groups compared with in
the primary group (p0.001 ; Table 2).
Macroscopic morphology of advanced neoplasms
Next, we excluded the 217 cancers withT2 from the 922 ad-
vanced neoplasms, and the 705 remaining advanced neoplasms
(545 primary lesions and 160 PCANs) were subjected to analysis
of the tumor morphology (Table 3). The 705 advanced neoplasms
were macroscopically divided into two groups : the polypoid and
non-polypoid groups. Generally, many LST-G lesions possess a
polypoid component ; therefore, LST-G was included as a subgroup
of the polypoid group in this study. The non-polypoid group included
three types of lesions : flat, depressed, and LST-NG lesions. The
incidence of non-polypoid lesions was significantly higher in the
PCAN3 y (25.2%, p0.001) and PCAN5 y groups (25.6%, p
0.001) than in the primary group (12.3%). Among the subgroups of
the non-polypoid group, the incidences of flat lesions (10 mm)
were significantly higher (p0.001) in the PCAN3 y (9.4%) and
PCAN5 y (10.0%) groups compared with that in the primary group
(2.2%). A significantly higher incidence of LST-NG in PCANs was
observed only when comparing between the PCAN5 y and pri-
mary groups (p0.05). We also examined the distribution of tumor
morphology between the PCAN3 y and PCAN 4-5 y groups, and
confirmed that there was no significant difference (p=0.771).
Cases withT1 cancer detected within 5 years after colonoscopy
Among the 258 cancers withT1 detected during the test pe-
riod, 12 lesions were detected within 5 years after colonoscopy (so-
called “interval cancers” ; Table 4). As described above, 7/12 le-
sions (58.3%) wereT2 cancers, and one case had distant metastasis
Table 2. Localization and histological features of 922 advanced neoplasms
Location or histology Primary lesions(% of 755 lesions)
PCAN3 y
(% of 142 lesions)
PCAN5 y
(% of 167 lesions)
Right -sided colon 257 (34.0%) 65 (45.8%)b 81 (48.5%)a
Cecum 51 (6.8%) 6 (4.2%) 7 (4.2%)
Ascending colon 136 (18.0%) 34 (23.9%) 41 (24.6%)
Transverse colon 70 (9.3%) 25 (17.6%)b 33 (19.8%)a
Left -sided colon and rectum 498 (66.0%) 77 (54.2%)b 86 (51.5%)a
Descending colon 52 (6.9%) 15 (10.6%) 17 (10.2%)
Sigmoid colon 298 (39.5%) 49 (34.5%) 54 (32.3%)
Rectum 148 (19.6%) 13 (9.2%)b 15 (9.0%)b
Adenoma with low-grade dysplasia 66 (8.7%) 16 (11.3%) 21 (12.6%)
Villous adenoma 18 (2.4%) 12 (8.5%)a 16 (9.6%)a
Traditional serrated adenoma 9 (1.2%) 1 (0.7%) 1 (0.6%)
Adenoma with high-grade dysplasia (including mucosal cancer) 382 (50.6%) 103 (72.5%)a 115 (68.9%)a
T1 cancer 246 (32.6%) 8 (5.6%)a 12 (7.2%)a
Well -differentiated 198 5 8
Moderately differentiated 39 3 4
Poorly differentiated 6 0 0
Mucinous adenocarcinoma 3 0 0
Unknown 34 (4.5%) 2 (1.4%) 2 (1.2%)
PCAN3 y, post -colonoscopy advanced neoplasms detected 0.5 -3.5 years after a previous negative colonoscopy ; PCAN 4-5 y, post -colonoscopy
advanced neoplasms detected 3.5 -5.5 years after a previous negative colonoscopy ; PCAN5 y, post -colonoscopy advanced neoplasms detected
0.5 -5.5 years after a previous negative colonoscopy. PCAN5 y includes PCAN3 y and PCAN 4-5 y lesions.
aSignificantly different compared with primary advanced neoplasms (p0.001).
bSignificantly different compared with primary advanced neoplasms (p0.01).
Table 3. Morphological characteristics of 705 advanced neoplasms, excludingT2 cancers
Macroscopic morphology Primary lesions(% of 545 lesions)
PCAN3 y
(% of 139 lesions)
PCAN5 y
(% of 160 lesions)
Polypoid group 478 (87.7%) 104 (74.8%)a 119 (74.4%)a
Polypoid 443 (81.3%) 98 (70.5%)b 113 (70.6%)b
LST-G 35 (6.4%) 6 (4.3%) 6 (3.8%)
Non-polypoid group 67 (12.3%) 35 (25.2%)a 41 (25.6%)a
Flat (10 mm) 12 (2.2%) 13 (9.4%)a 16 (10.0%)a
Depressed 9 (1.7%) 3 (2.2%) 3 (1.9%)
LST-NG 46 (8.4%) 19 (13.7%) 22 (13.8%)c
LST-G, laterally spreading tumor granular type ; LST-NG, laterally spreading tumor non-granular.
aSignificantly different compared with primary advanced neoplasms (p0.001).
bSignificantly different compared with primary advanced neoplasms (p0.01).
cSignificantly different compared with primary advanced neoplasms (p0.05).
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(Stage IV). Five of these 12 lesions (42%) were right-sided. As for
the previous colonoscopic findings, 5/12 cases (42%) were nega-
tive, whereas small adenomas or sessile serrated adenoma/polyps
(SSA/Ps) were detected in another segment from interval cancers
in 6/12 cases (50%).
DISCUSSION
Screening and removal of precancerous lesions upon colono-
scopy are indispensable for the prevention of CRC (2-5). Analysis
of 5,768 colonoscopies for 4,841 patients in this study showed that
246 cancers withT1 were detected in 234 (7.8%) of the 2,979 pa-
tients undergoing colonoscopy for the first time or repeated colono-
scopy after more than a 5.5-year interval, whereas this incidence
was decreased to 0.4% (12 cases) of the 2,789 patients undergoing
a repeated colonoscopy within 5.5 years (PCAN5 y). Among the
12 cancers withT1 in the PCAN5 y group, 7 lesions wereT2
cancers. The remaining 160 PCANs were still early -stage cancers.
Thus, our results confirm the importance of colonoscopy to reduce
the risk for life - threatening CRC.
At the same time, however, a significant number of advanced
neoplasms could be detected as PCANs. It might be difficult to
determine whether the detected PCANs were caused by missed
lesions or rapid growth of the lesions. In this regard, a number of
recent researches have suggested that most cases of interval can-
cers are caused by missed lesions in the previous colonoscopy
(6, 10, 16-20). Therefore, it is particularly important to reveal the
crucial factors related to why the lesions were missed at the previ-
ous colonoscopy. Several studies have shown that the prevalence
of right-sided CRC is not successfully reduced after colonoscopy
as compared with left -sided CRC (3, 4, 27-29). In agreement with
those reports, the incidence of right-sided lesions was significantly
higher in PCANs than in primary lesions in the present study. To
more strictly examine missed, advancedre neoplasms after colono-
scopy, we also analyzed PCANs detected within 3.5 years after the
previous colonoscopy (PCAN3 y). However, even in this case,
the incidence of right-sided lesions was significantly higher in
PCANs compared with that in primary lesions. The different bio-
logical features of right-sided lesions and higher probability of
missing lesions in the right-sided colon may explain the lack of
reduction in right-sided CRC (6, 16, 17).
Although the distribution and risk factors of interval cancers after
negative colonoscopy have been extensively studied, the macro-
scopic tumor morphology has not been investigated in detail. This
investigation is particularly important from the viewpoint of over-
sight. Non-polypoid neoplasms are typically located in the right-
sided colon (30, 31). The importance of non-polypoid lesions was
advocated by Kudo et al. in the 1990s in Japan (32), and non-poly-
poid neoplasms are now relatively common even in Western coun-
tries (33-39). Meanwhile, LST has been recognized as a type of
non-polypoid lesion (31, 40-43). As for the molecular biological
mechanism, non-polypoid neoplasms differ from polypoid lesions.
Especially, one study suggested that depressed and LST-NG lesions
less frequently show KRAS mutations compared to polypoid lesions
(44), whereas these mutations are relatively common in LST-G
(41). Based onthese findings, in this study, LST-G was classified
into the polypoid group, because the characteristics of LST-G are
consider to differ from those of other non-polypoid lesions.
As a result, we found that the incidence of non-polypoid lesions
was significantly higher in the PCAN5 y group than in the pri-
mary group. Especially, the rates of flat lesions (10 mm) and LST-
NGs were higher in the PCAN5 y group than in the primary
group. The morphology of early -stage de novo cancer has been
considered to frequently be non-polypoid, especially the depressed
type (45) ; these cancers can rapidly grow and invade deep into the
tissue, while the tumors still appear small. In this study, there was
no significant difference in the incidence of depressed polyps be-
tween primary lesions and PCANs ; we identified 3 (1.9%) and 9
lesions (1.7%) of depressed polyps in the 545 primary lesions and
160 PCANs, respectively. In contrast, LST-NG lesions represented
the majority of non-polypoid PCANs in the present study. LST-NG
lesions can be easily missed upon colonoscopy because of their
flat shape, indicating that LST-NG lesions might be an important
candidate precursor for interval CRC.
SSA/P is also typically located in the right-sided colon and has
been recently recognized as a precursor to CRC (46). Accordingly,
the difficulty of SSA/P detection via colonoscopy is noted as one of
the factors impeding early prevention of interval cancers in the
right-sided colon. However, SSA/P was not included as an end-
point in this study.
We also analyzed PCANs detected 3.5 to 5.5 years after the pre-
vious colonoscopy (PCAN 4-5 y) to test whether PCANs displayed
somewhat different characteristics depending on the interval after
Table 4. Cases withT1 cancer detected within 5 years after colonoscopy
Age
(y)
Sex Location Morphology Histology Stage Previous colonoscopy Findings of previous colonoscopy
(location)
62 F A 2 Wel III 4 years ago Negative
61 M A 0-IIc Mod I One year ago Small adenoma (D)a
80 M A 2 Mod II 5 years ago Negative
82 F T 2 Wel IV 3 years ago Negative
72 F T 2 Mod I One year ago Small adenoma (S)b and SSA/P (A)b
43 M S 0-Ip Wel I 2 years ago Negative
65 M S 0-IIa+IIc (LST-NG) Wel I 3 years ago Small adenoma (T)a
78 F R 2 Wel II One year ago T3 cancer (S)c
60 M R 0-Is Wel I 3 years ago Small adenoma (S)a
50 F R 0-IIa+Is (LST-G) Mod I 3 years ago Negative
67 M R 2 Mod III 4 years ago Small adenoma (S)d
77 M R 2 Wel II 5 years ago Small adenoma (S)b
A, ascending colon ; T, transverse colon ; D, descending colon, S, sigmoid colon ; R, rectum, Wel, well -differentiated adenocarcinoma ; Mod, mod-
erately differentiated adenocarcinoma ; LST-NG ; laterally spreading tumor non-granular type ; SSA/P, sessile serrated adenoma/polyp.
Morphology was categorized according to the Paris classification. Cancer stage was decided according to the American Joint Committee on Can-
cer/TNM system. aRemoved by cold polypectomy. bRemoved by endoscopic mucosal resection. cRemoved by surgical intervention. dNot removed.
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colonoscopy. The location and morphological features of the PCAN
3 y group were similar to those of the PCAN 4-5 y group, suggest-
ing that most PCANs were likely to be missed, slowly growing le-
sions.
Despite the fact that the proportions of non-polypoid and right-
sided lesions in PCANs are high, polypoid and left-sided lesions
are still considered important, as they account for the highest
number of total lesions. In the present study, more than half of all
cancers withT1 detected within 5 years after colonoscopy were
left -sided lesions. Hence, we should still pay close attention to left -
sided and polypoid lesions in order to prevent interval CRC.
Recently, several instruments and techniques to identify and
prevent missed lesions located behind the folds have been re-
ported, including cap-assisted colonoscopy (47), the retroflection
technique (48, 49), and various novel types of colonoscopies to
improve the polyp detection rate (50). These techniques may prove
to be useful especially in the right-side colon, as the frequency of
folds in the right-sided colon tends to be high. Furthermore, im-
age-enhanced endoscopy has also been discussed for the detec-
tion of colorectal polyps (51-53). The rate of missed lesions may
decrease in the future using these novel endoscopies and tech-
niques.
This study has several limitations. First, it is a retrospective,
single-center study. Second, patients who undergo repeated colono-
scopy are often at relatively high risk for CRC and may hence not
represent the general population. Third, the quality of the previous
colonoscopy (e.g. preparation status) could not be evaluated in this
study. However, despite these limitations, the results of this study
provide important information about the characteristics of lesions
detected after colonoscopy. In particular, careful attention should
be paid to non-polypoid and right-sided lesions during screening
and surveillance colonoscopy.
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